Myogen【MYOG】銘柄情報

個人投資家向けのプロ仕様のツール。

プレミアム

通貨

買値

売値

出来高

0.00 日の範囲 0.00

0.00 52 週間の範囲 0.00

前日終値

始値

時刻

最終取引時間

平均取引量 (3 か月)

財務取引量

VWAP

Gilead Sciences Completes Acquisition of Myogen

Gilead Sciences, Inc. (Nasdaq:GILD) announced today that it has completed its acquisition of Myogen, Inc. (Nasdaq:MYOG). On November 17, 2006, Gilead caused one of its...

Darusentan Data to Be Presented at AHA 2006 -- Chicago

Myogen, Inc. (Nasdaq: MYOG), a biopharmaceutical company focused on the discovery, development and commercialization of small molecule therapeutics for the treatment of...

Darusentan Data to Be Presented at ISH 2006 -- Fukuoka, Japan

Myogen, Inc. (Nasdaq: MYOG), a biopharmaceutical company focused on the discovery, development and commercialization of small molecule therapeutics for the treatment of...

Four Ambrisentan Studies to Be Presented at Chest 2006 -- Salt Lake City

Myogen, Inc. (Nasdaq: MYOG), a biopharmaceutical company focused on the discovery, development and commercialization of small molecule therapeutics for the treatment of...

Seven Summits Research Releases Comments on GOOG, ABX, HET, CBS, and MYOG

CHICAGO, Oct. 2 /PRNewswire/ -- Seven Summits Research Releases NewsBites on key stocks. Seven Summits Strategic Investments NewsBites are available to all investors at...

Gilead Sciences to Acquire Myogen, Inc. for $2.5 Billion

Gilead Sciences, Inc. (Nasdaq:GILD) and Myogen, Inc. (Nasdaq:MYOG) announced today that the companies have signed a definitive agreement under which Gilead plans to acquire...

Myogen to Present at the UBS Global Life Sciences Conference

Myogen, Inc. (Nasdaq: MYOG), a biopharmaceutical company focused on the discovery, development and commercialization of small molecule therapeutics for the treatment of cardiovascular...

Myogen Initiates Open-Label Phase 3 Clinical Trial of Ambrisentan in Patients with Pulmonary Hypertension

Myogen, Inc. (Nasdaq: MYOG), a biopharmaceutical company focused on the discovery, development and commercialization of small molecule therapeutics for the treatment of cardiovascular...

The American Lung Association and Myogen Announce Pulmonary Arterial Hypertension Educational Partnership

The American Lung Association and Myogen, Inc. (Nasdaq: MYOG) today announced that they will collaborate on a new public awareness initiative to educate the public about pulmonary...

Myogen Reports 2006 Second Quarter Results

Myogen, Inc. (Nasdaq:MYOG), a biopharmaceutical company focused on the discovery, development and commercialization of small molecule therapeutics for the treatment of cardiovascular...

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

出来高
値上がり率
値下がり率

銘柄コード	株価	出来高
PDYNPalladyne AI Corporation	US$ 4.59 (129.50%)	83.07M
QMCOQuantum Corporation	US$ 9.11 (126.62%)	39.48M
NANano Labs Ltd	US$ 8.26 (89.02%)	2.03M
XCURExicure Inc	US$ 18.60 (71.27%)	4.59M
SKKSKK Holdings Limited	US$ 1.75 (59.09%)	107.47M
AMIXAutonomix Medical Inc	US$ 6.21 (-54.07%)	946.09k
CETXCemtrex Inc	US$ 0.1146 (-41.74%)	24.39M
MSWMing Shing Group Holdings Ltd	5.90 (-35.52%)	417.08k
RMSGReal Messenger Corporation	US$ 3.09 (-26.25%)	313.51k
ENSCEnsysce Biosciences Inc	US$ 0.4414 (-25.49%)	4M
ELABElevai Labs Inc	US$ 0.0201 (-0.50%)	415.87M
NVDANVIDIA Corporation	US$ 141.95 (-3.22%)	229.93M
SMCISuper Micro Computer Inc	US$ 33.15 (11.62%)	155.43M
VRPXVirpax Pharmaceuticals Inc	US$ 0.5501 (-6.72%)	154.17M
SOUNSoundHound AI Inc	US$ 8.24 (18.05%)	103.6M